The Acute Effects of Blood Flow Restriction on Ankle Muscle Reaction Time and Proprioception in Healthy Individuals

December 14, 2025 updated by: Melike Tugran, Uludag University
his randomized controlled crossover study aims to investigate the acute effects of lower limb blood flow restriction (BFR) on ankle joint proprioception, postural control, and muscle activation in healthy adults. Each participant will complete test sessions under BFR (60% individualized arterial occlusion pressure) and control (20 mmHg sham) conditions. Outcome measures include joint position sense, kinesthesia, static and dynamic balance performance, and electromyographic (EMG) activity and reaction times of selected lower limb tibialis anterior and peroneus longus muscles.

Study Overview

Detailed Description

Lateral ankle sprains are among the most common musculoskeletal injuries and may lead to chronic ankle instability (CAI), partly due to impaired proprioception and neuromuscular control. Blood flow restriction (BFR) training is widely used to augment muscular adaptations with low external loads; however, its acute effects on joint proprioception and sensorimotor control, particularly at the ankle joint, remain unclear and may be detrimental under certain conditions. This randomized controlled crossover trial will examine the effects of a single-session lower limb BFR application on ankle joint position sense, kinesthesia, static and dynamic balance, and EMG-based reaction time and activity of lower limb muscles in healthy adults. Participants aged 18-40 years without recent ankle sprain, neuromuscular, cardiovascular, or thromboembolic disease will undergo standardized proprioception tests using an isokinetic dynamometer, static balance tests on a force platform, Y-balance test, and inversion simulation platform assessments under BFR (60% arterial occlusion pressure) and low-pressure control (20 mmHg) conditions. Individual arterial occlusion pressure (AOP) will be determined using Doppler ultrasound, and BFR will be applied with a pneumatic cuff at the most proximal thigh. All measurements will be performed on the dominant lower limb with sessions scheduled at the same time of day to minimize circadian variability. The primary hypothesis is that acute lower limb BFR will worsen ankle joint proprioception and sensorimotor control compared with the control condition, potentially indicating a transient increase in injury risk during BFR-assisted activities.

Study Type

Interventional

Enrollment (Estimated)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged between 18 and 40 years
  • No known neuromuscular or cardiovascular disease

Exclusion Criteria:

  • History or presence of cardiac, coronary artery, or peripheral arterial disease
  • Presence or history of varicose veins, hypertension, diabetes mellitus, or pulmonary disease
  • History of pulmonary embolism or deep vein thrombosis
  • Use of medications affecting the central nervous or cardiovascular systems
  • Use of oral contraceptives or anticoagulants
  • Pregnancy
  • Open wounds or significant scar tissue at the cuff application site
  • History of lower extremity musculoskeletal injury or surgery
  • Any neurological, vascular, or systemic condition that may interfere with test performance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Blood Flow Restriction
Participants perform balance/proprioception tests under lower limb blood flow restriction at % 60 AOP.
Arm Description: Participants perform balance/proprioception tests under lower limb blood flow restriction at % 60 AOP.
Sham Comparator: Sham BFR
Sham BFR Description: Participants perform the same tests with sham(20 mmHg) blood flow restriction
Sham BFR Description: Participants perform the same tests with sham(20 mmHg) blood flow restriction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Ankle Joint Position Sense Error (degrees)
Time Frame: day 1 and day 2
Absolute error (degrees) between target and reproduced angles during passive and active joint position sense tests in inversion and plantar flexion, measured with an isokinetic dynamometer.
day 1 and day 2
Static Balance Performance
Time Frame: day 3
Center of pressure path length (mm) in single-leg and tandem stance with eyes open/closed on force platform (HUR SmartBalance).
day 3
Change in Kinesthesia Threshold (degrees)
Time Frame: day 1 and day 2
Minimal angular displacement (degrees) at which movement is first perceived in inversion and plantarflexion.
day 1 and day 2
Static balance performance
Time Frame: day 3
sway velocity (mm/s) in single-leg and tandem stance with eyes open/closed on force platform (HUR SmartBalance).
day 3
static balance performance
Time Frame: day 3
sway area (mm^2) in single-leg and tandem stance with eyes open/closed on force platform (HUR SmartBalance).
day 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Y-Balance Test Reach Distances (cm)
Time Frame: day 4
Anterior, posteromedial and posterolateral reach distances of the tested limb.
day 4
Peroneus Longus and Tibialis Anterior Reaction Time (ms)
Time Frame: day 4
Time from onset of platform-induced inversion to EMG activation exceeding 2× resting activity.
day 4
Lower Limb EMG Activity (%MVIC)
Time Frame: day 4
Mean EMG amplitude normalized to maximal voluntary isometric contraction values.
day 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: ufuk sekir, Department of Sports Medicine, Bursa Uludağ University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

January 10, 2026

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

December 14, 2025

First Posted (Actual)

December 29, 2025

Study Record Updates

Last Update Posted (Actual)

December 29, 2025

Last Update Submitted That Met QC Criteria

December 14, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Flow Restriction

Clinical Trials on Blood Flow Restriction

Subscribe